Alumis ALMS
NASDAQ ALMS
$11.16 -0.20 (-1.76%)
As of: Sep 4, 2026 · 2:40 PM EDT

Alumis (ALMS) Cash & Equivalents (QoQ) (2023 - 2025)

Analysis

Alumis (ALMS) Cash & Equivalents (QoQ) (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.74 Bn 130.89 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.52 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.04 Bn 52.91 Bn 52.00 Mn
5 Revolution Medicines 44.06 Bn 44.06 Bn -
6 BeOne Medicines 39.98 Bn 34.88 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.46 Bn 32.15 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Alumis 1.43 Bn 923.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 37.41%
Sep 30, 2025 -57.00%
Jun 30, 2025 18.06%
Mar 31, 2025 -24.18%
Dec 31, 2024 -20.57%
Sep 30, 2024 37.59%
Jun 30, 2024 38.40%
Mar 31, 2024 143.65%
Dec 31, 2023 -14.72%
Sep 30, 2023 -32.21%